Follicular lymphoma (FL) is the second most frequent subtype of non-Hodgkin lymphoma, a cancer of the immune system. Although ...
Incannex Healthcare Inc. (NASDAQ:IXHL) surged 19.2% in premarket trading on Wednesday after revealing that the U.S. Food and Drug Administration has granted Fast Track status to IHL-42X, its ...
Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad ...
Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...